These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9920350)

  • 1. Complement and atherogenesis: the unknown connection.
    Bhakdi S
    Ann Med; 1998 Dec; 30(6):503-7. PubMed ID: 9920350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of atherosclerosis: infectious versus immune pathogenesis. A new concept.
    Bhakdi S
    Herz; 2000 Mar; 25(2):84-6. PubMed ID: 10829244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An alternative hypothesis of the pathogenesis of atherosclerosis].
    Bhakdi S
    Herz; 1998 May; 23(3):163-7. PubMed ID: 9646097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety.
    Bhakdi S; Dorweiler B; Kirchmann R; Torzewski J; Weise E; Tranum-Jensen J; Walev I; Wieland E
    J Exp Med; 1995 Dec; 182(6):1959-71. PubMed ID: 7500042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae and atherosclerosis: links to the disease process.
    Byrne GI; Kalayoglu MV
    Am Heart J; 1999 Nov; 138(5 Pt 2):S488-90. PubMed ID: 10539855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages.
    Klouche M; Gottschling S; Gerl V; Hell W; Husmann M; Dorweiler B; Messner M; Bhakdi S
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1376-85. PubMed ID: 9743225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.
    Torzewski M; Klouche M; Hock J; Messner M; Dorweiler B; Torzewski J; Gabbert HE; Bhakdi S
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):369-78. PubMed ID: 9514405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
    Torzewski M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond cholesterol: the enigma of atherosclerosis revisited.
    Bhakdi S; Lackner KJ; Han SR; Torzewski M; Husmann M
    Thromb Haemost; 2004 Apr; 91(4):639-45. PubMed ID: 15045123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and atherosclerosis-united to the point of no return?
    Torzewski M; Bhakdi S
    Clin Biochem; 2013 Jan; 46(1-2):20-5. PubMed ID: 23010447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation by oxidatively modified low-density lipoproteins.
    Wieland E; Dorweiler B; Bonitz U; Lieser S; Walev I; Bhakdi S
    Eur J Clin Invest; 1999 Oct; 29(10):835-41. PubMed ID: 10583425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae.
    Kalayoglu MV; Hoerneman B; LaVerda D; Morrison SG; Morrison RP; Byrne GI
    J Infect Dis; 1999 Sep; 180(3):780-90. PubMed ID: 10438367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.
    Hu H; Pierce GN; Zhong G
    J Clin Invest; 1999 Mar; 103(5):747-53. PubMed ID: 10074493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidized low density lipoprotein in atherogenesis.
    Witztum JL; Steinberg D
    J Clin Invest; 1991 Dec; 88(6):1785-92. PubMed ID: 1752940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of macrophage foam cell formation by Chlamydia pneumoniae.
    Kalayoglu MV; Byrne GI
    J Infect Dis; 1998 Mar; 177(3):725-9. PubMed ID: 9498454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
    Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
    Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.